论文信息 - Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients with Newly Diagnosed FLT3-Mutant Acute Myeloid Leukemia (AML). - 字舞流文

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients with Newly Diagnosed FLT3-Mutant Acute Myeloid Leukemia (AML).

M. Konopleva | M. Andreeff | H. Kantarjian | G. Garcia-Manero | J. Cortes | F. Ravandi | G. Borthakur | S. Faderl | M. Brandt | A. Al-Kali | Xue Ao | Dan Jones